Cargando…

Binge Eating and Compulsive Buying During Cabergoline Treatment for Prolactinoma: A Case Report

Prolactinomas are the most prevalent functional pituitary adenomas. They are usually treated clinically with dopamine agonists. The most widely used and suitable drug is cabergoline (CAB), a specific D2 dopamine agonists. Patients in prolactinoma treatment with CAB commonly report physical side effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correa e Castro, Ana Carolina, de Araujo, Andressa Alexandre, Botelho, Mariana Coelho, Nascimento, João Bosco, de Souza, Rafaela Marchon, Gadelha, Monica Roberto, Nardi, Antonio E., Violante, Alice Helena Dutra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178067/ https://www.ncbi.nlm.nih.gov/pubmed/35693961 http://dx.doi.org/10.3389/fpsyt.2022.844718

Ejemplares similares

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Spontaneous reduction of prolactinoma post cabergoline withdrawal
por: Venkatesh, Sampath Kumar, et al.
Publicado: (2012)

Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
por: Ghadirian, Hesam, et al.
Publicado: (2018)

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
por: Hayes, Annabelle G, et al.
Publicado: (2022)

Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
por: Pala, Nazir A., et al.
Publicado: (2015)

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
por: Khare, Shruti, et al.
Publicado: (2017)

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline
por: Calva-González, Metztli, et al.
Publicado: (2023)

Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma
por: Doğan, Berçem Ayçiçek, et al.
Publicado: (2016)

Cabergoline treatment in prolactinoma: Amelioration in obstructive and central sleep apneas
por: Binar, M, et al.
Publicado: (2019)

Abstract 94: Efficacy of cabergoline treatment in men with giant prolactinomas
Publicado: (2022)

MON-LB60 Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Prospective Study
por: Corrêa Portari, Luiz Henrique, et al.
Publicado: (2020)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021)

Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?
por: Vilar, Lucio, et al.
Publicado: (2015)

Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
por: Cho, Eun-Hee, et al.
Publicado: (2009)

Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline
por: Almistehi, Wael M, et al.
Publicado: (2018)

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
por: Menon, Lakshmi P., et al.
Publicado: (2021)

SUN-445 A Brazilian Multicentric Study Evaluating Pregnancies Induced by Cabergoline in Patients Harboring Prolactinomas
por: Sant Anna, Beatriz, et al.
Publicado: (2019)

Body self-image disturbances in women with prolactinoma
por: Pereira, Helen S., et al.
Publicado: (2019)

Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline
por: Astaf’eva, Ludmila, et al.
Publicado: (2020)

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021)

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2023)

De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
por: Belhadj Slimane, Chayma, et al.
Publicado: (2023)

The Roles of Anxiety and Self-Esteem in the Risk of Eating Disorders and Compulsive Buying Behavior
por: De Pasquale, Concetta, et al.
Publicado: (2022)

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy
por: Bajwa, Sukhwinder Kaur, et al.
Publicado: (2011)

Cabergoline Effectively Induced Remission of Prolactinoma in a 9-year-old Japanese Boy
por: Sano, Hitomi, et al.
Publicado: (2009)

SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019)

SAT-246 A Case of Cabergoline Induced Pituitary Apoplexy in a Patient with Prolactinoma
por: Ahuja, Ashim
Publicado: (2020)

A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma
por: Ikeda, Shinichiro, et al.
Publicado: (2020)

Foster Kennedy syndrome secondary to a giant prolactinoma with a remarkable response to cabergoline
por: Kanj, Usama, et al.
Publicado: (2022)

FRI321 Aggressive Prolactinoma Empirically Treated With Cabergoline Leading To Rapid CSF Leak
por: Yau, Alice, et al.
Publicado: (2023)

A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas
por: Mishra, Rakesh, et al.
Publicado: (2021)

Preventing Binge Eating with Deep Brain Stimulation – Can Compulsive Eating be Switched Off?
por: Martire, Sarah I., et al.
Publicado: (2013)

A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder
por: Yee, Karen, et al.
Publicado: (2019)

Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma
por: Singh, Pratibha, et al.
Publicado: (2011)

Rapid reduction with cystic transformation of invasive giant prolactinoma following short term low dose cabergoline
por: Dutta, Deep, et al.
Publicado: (2012)

Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report
por: Casulari, Luiz Augusto, et al.
Publicado: (2019)

Subarachnoid Hemorrhage Due to Rupture of an Intracavernous Carotid Artery Aneurysm Coexisting with a Prolactinoma under Cabergoline Treatment
por: Akutsu, Nobuyuki, et al.
Publicado: (2014)

Boundaries between compulsive buying and hoarding regarding the obsessive-compulsive spectrum
por: Moreno, L., et al.
Publicado: (2021)

ODP328 Longitudinal Multidisciplinary Approach for Cabergoline-Resistant Aggressive Prolactinoma Complicated by Multiple Endocrine Neoplasia Type 1
por: Furusawa, Sho, et al.
Publicado: (2022)

Binge-eating disorder in students: high prevalence and strong link to impulsive and compulsive traits
por: Solly, Jeremy E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_acrtb1ak7uk0mj7hadv1i8fgnp